These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 34432198)

  • 1. PFKFB3 gene deletion in endothelial cells inhibits intraplaque angiogenesis and lesion formation in a murine model of venous bypass grafting.
    Perrotta P; de Vries MR; Peeters B; Guns PJ; De Meyer GRY; Quax PHA; Martinet W
    Angiogenesis; 2022 Feb; 25(1):129-143. PubMed ID: 34432198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial specific SIRT3 deletion impairs glycolysis and angiogenesis and causes diastolic dysfunction.
    He X; Zeng H; Chen ST; Roman RJ; Aschner JL; Didion S; Chen JX
    J Mol Cell Cardiol; 2017 Nov; 112():104-113. PubMed ID: 28935506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycolytic PFKFB3 and Glycogenic UGP2 Axis Regulates Perfusion Recovery in Experimental Hind Limb Ischemia.
    Jaiyesimi O; Kuppuswamy S; Zhang G; Batan S; Zhi W; Ganta VC
    Arterioscler Thromb Vasc Biol; 2024 Aug; 44(8):1764-1783. PubMed ID: 38934117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial Inhibition of Glycolysis Reduces Atherogenesis Independent of Intraplaque Neovascularization in Mice.
    Perrotta P; Van der Veken B; Van Der Veken P; Pintelon I; Roosens L; Adriaenssens E; Timmerman V; Guns PJ; De Meyer GRY; Martinet W
    Arterioscler Thromb Vasc Biol; 2020 May; 40(5):1168-1181. PubMed ID: 32188275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laminar shear stress inhibits endothelial cell metabolism via KLF2-mediated repression of PFKFB3.
    Doddaballapur A; Michalik KM; Manavski Y; Lucas T; Houtkooper RH; You X; Chen W; Zeiher AM; Potente M; Dimmeler S; Boon RA
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):137-45. PubMed ID: 25359860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphotoxin-α promotes tumor angiogenesis in HNSCC by modulating glycolysis in a PFKFB3-dependent manner.
    Yang JG; Wang WM; Xia HF; Yu ZL; Li HM; Ren JG; Chen G; Wang BK; Jia J; Zhang W; Zhao YF
    Int J Cancer; 2019 Sep; 145(5):1358-1370. PubMed ID: 30785217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incomplete and transitory decrease of glycolysis: a new paradigm for anti-angiogenic therapy?
    Schoors S; Cantelmo AR; Georgiadou M; Stapor P; Wang X; Quaegebeur A; Cauwenberghs S; Wong BW; Bifari F; Decimo I; Schoonjans L; De Bock K; Dewerchin M; Carmeliet P
    Cell Cycle; 2014; 13(1):16-22. PubMed ID: 24335389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of PFKFB3-driven glycolysis in vessel sprouting.
    De Bock K; Georgiadou M; Schoors S; Kuchnio A; Wong BW; Cantelmo AR; Quaegebeur A; Ghesquière B; Cauwenberghs S; Eelen G; Phng LK; Betz I; Tembuyser B; Brepoels K; Welti J; Geudens I; Segura I; Cruys B; Bifari F; Decimo I; Blanco R; Wyns S; Vangindertael J; Rocha S; Collins RT; Munck S; Daelemans D; Imamura H; Devlieger R; Rider M; Van Veldhoven PP; Schuit F; Bartrons R; Hofkens J; Fraisl P; Telang S; Deberardinis RJ; Schoonjans L; Vinckier S; Chesney J; Gerhardt H; Dewerchin M; Carmeliet P
    Cell; 2013 Aug; 154(3):651-63. PubMed ID: 23911327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockage of glycolysis by targeting PFKFB3 suppresses the development of infantile hemangioma.
    Yang K; Qiu T; Zhou J; Gong X; Zhang X; Lan Y; Zhang Z; Ji Y
    J Transl Med; 2023 Feb; 21(1):85. PubMed ID: 36740704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial Inhibition of the 6-Phosphofructo-2-Kinase/Fructose-2,6-Bisphosphatase-3 (PFKFB3) Enzyme in Myeloid Cells Does Not Affect Atherosclerosis.
    Tillie RJHA; De Bruijn J; Perales-Patón J; Temmerman L; Ghosheh Y; Van Kuijk K; Gijbels MJ; Carmeliet P; Ley K; Saez-Rodriguez J; Sluimer JC
    Front Cell Dev Biol; 2021; 9():695684. PubMed ID: 34458258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial PFKFB3 plays a critical role in angiogenesis.
    Xu Y; An X; Guo X; Habtetsion TG; Wang Y; Xu X; Kandala S; Li Q; Li H; Zhang C; Caldwell RB; Fulton DJ; Su Y; Hoda MN; Zhou G; Wu C; Huo Y
    Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1231-9. PubMed ID: 24700124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial and transient reduction of glycolysis by PFKFB3 blockade reduces pathological angiogenesis.
    Schoors S; De Bock K; Cantelmo AR; Georgiadou M; Ghesquière B; Cauwenberghs S; Kuchnio A; Wong BW; Quaegebeur A; Goveia J; Bifari F; Wang X; Blanco R; Tembuyser B; Cornelissen I; Bouché A; Vinckier S; Diaz-Moralli S; Gerhardt H; Telang S; Cascante M; Chesney J; Dewerchin M; Carmeliet P
    Cell Metab; 2014 Jan; 19(1):37-48. PubMed ID: 24332967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ablation of endothelial Pfkfb3 protects mice from acute lung injury in LPS-induced endotoxemia.
    Wang L; Cao Y; Gorshkov B; Zhou Y; Yang Q; Xu J; Ma Q; Zhang X; Wang J; Mao X; Zeng X; Su Y; Verin AD; Hong M; Liu Z; Huo Y
    Pharmacol Res; 2019 Aug; 146():104292. PubMed ID: 31167111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The PFKFB3 Inhibitor AZ67 Inhibits Angiogenesis Independently of Glycolysis Inhibition.
    Emini Veseli B; Van Wielendaele P; Delibegovic M; Martinet W; De Meyer GRY
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YAP promotes ocular neovascularization by modifying PFKFB3-driven endothelial glycolysis.
    Feng Y; Zou R; Zhang X; Shen M; Chen X; Wang J; Niu W; Yuan Y; Yuan F
    Angiogenesis; 2021 Aug; 24(3):489-504. PubMed ID: 33400016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small molecule 3PO inhibits glycolysis but does not bind to 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3).
    Emini Veseli B; Perrotta P; Van Wielendaele P; Lambeir AM; Abdali A; Bellosta S; Monaco G; Bultynck G; Martinet W; De Meyer GRY
    FEBS Lett; 2020 Sep; 594(18):3067-3075. PubMed ID: 32620030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PFKFB3-mediated endothelial glycolysis promotes pulmonary hypertension.
    Cao Y; Zhang X; Wang L; Yang Q; Ma Q; Xu J; Wang J; Kovacs L; Ayon RJ; Liu Z; Zhang M; Zhou Y; Zeng X; Xu Y; Wang Y; Fulton DJ; Weintraub NL; Lucas R; Dong Z; Yuan JX; Sullivan JC; Meadows L; Barman SA; Wu C; Quan J; Hong M; Su Y; Huo Y
    Proc Natl Acad Sci U S A; 2019 Jul; 116(27):13394-13403. PubMed ID: 31213542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axitinib attenuates intraplaque angiogenesis, haemorrhages and plaque destabilization in mice.
    Van der Veken B; De Meyer GRY; Martinet W
    Vascul Pharmacol; 2018 Jan; 100():34-40. PubMed ID: 29079346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory role of TIGAR on endothelial metabolism and angiogenesis.
    He X; Zeng H; Cantrell AC; Chen JX
    J Cell Physiol; 2021 Nov; 236(11):7578-7590. PubMed ID: 33928637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PFKFB3-mediated glycometabolism reprogramming modulates endothelial differentiation and angiogenic capacity of placenta-derived mesenchymal stem cells.
    Zhang Y; Zhong Y; Liu W; Zheng F; Zhao Y; Zou L; Liu X
    Stem Cell Res Ther; 2022 Aug; 13(1):391. PubMed ID: 35918720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.